Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 november 2021 News Human COVID-19 Medicines EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 november 2021 News Human COVID-19 Medicines COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 november 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 november 2021 News Human COVID-19 Medicines First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 november 2021 News Human Medicines EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 november 2021 News Human COVID-19 Vaccines COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 november 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021 8 november 2021 News Veterinary Medicines EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly 2 november 2021 News Human COVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 29 oktober 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines 1 … 50 51 52 53 54 Page 54 of 379 55 56 57 58 … 379
EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 november 2021 News Human COVID-19 Medicines
EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 november 2021 News Human COVID-19 Medicines
COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 november 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 november 2021 News Human COVID-19 Medicines
First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 november 2021 News Human Medicines
EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 november 2021 News Human COVID-19 Vaccines
COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 november 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021 8 november 2021 News Veterinary Medicines
EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly 2 november 2021 News Human COVID-19
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 29 oktober 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines